Xonvea In The Uk What Is It Licenced For
Xonvea, a combination of doxylamine and pyridoxine, is the first medication specifically licensed for the treatment of nausea and vomiting in pregnant women. This is important as other antihistamines and phenothiazines may still be used for this purpose, despite not having specific licensing for pregnant women. In the UK, a delayed-release version of Xonvea is available for next day delivery and its effectiveness is comparable to combining cyclizine or promethazine with pyridoxine. This medication is welcomed by experts and prescribed to help alleviate morning sickness in pregnant women. It was licensed by Alliance Pharma from Canadian firm Duchesnay in 2015.
Xonvea is licensed in the UK specifically for the treatment of nausea and vomiting in pregnant women. This medication, which is a combination of doxylamine and pyridoxine, is the first of its kind to be licensed for this particular use. It provides a specific treatment option tailored to pregnant women experiencing these symptoms. The delayed-release version of Xonvea is available for next-day delivery. It's noteworthy that its effectiveness has been found to be comparable to combining cyclizine or promethazine with pyridoxine. Notably, Xonvea was licensed by Alliance Pharma from Canadian firm Duchesnay in 2015.
Sources
Related Questions
Work fast from anywhere
Stay up to date and move work forward with BrutusAI on macOS/iOS/web & android. Download the app today.